1
|
Hammad R, Alzubi J, Rhiel M, Chmielewski KO, Mosti L, Rositzka J, Heugel M, Lawrenz J, Pennucci V, Gläser B, Fischer J, Schambach A, Moritz T, Lachmann N, Cornu TI, Mussolino C, Schäfer R, Cathomen T. CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells. Int J Mol Sci 2024; 25:985. [PMID: 38256061 PMCID: PMC10816062 DOI: 10.3390/ijms25020985] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2023] [Revised: 01/04/2024] [Accepted: 01/09/2024] [Indexed: 01/24/2024] Open
Abstract
The CRISPR-Cas12a platform has attracted interest in the genome editing community because the prototypical Acidaminococcus Cas12a generates a staggered DNA double-strand break upon binding to an AT-rich protospacer-adjacent motif (PAM, 5'-TTTV). The broad application of the platform in primary human cells was enabled by the development of an engineered version of the natural Cas12a protein, called Cas12a Ultra. In this study, we confirmed that CRISPR-Cas12a Ultra ribonucleoprotein complexes enabled allelic gene disruption frequencies of over 90% at multiple target sites in human T cells, hematopoietic stem and progenitor cells (HSPCs), and induced pluripotent stem cells (iPSCs). In addition, we demonstrated, for the first time, the efficient knock-in potential of the platform in human iPSCs and achieved targeted integration of a GFP marker gene into the AAVS1 safe harbor site and a CSF2RA super-exon into CSF2RA in up to 90% of alleles without selection. Clonal analysis revealed bi-allelic integration in >50% of the screened iPSC clones without compromising their pluripotency and genomic integrity. Thus, in combination with the adeno-associated virus vector system, CRISPR-Cas12a Ultra provides a highly efficient genome editing platform for performing targeted knock-ins in human iPSCs.
Collapse
Affiliation(s)
- Ruba Hammad
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
- Freiburg iPS Core Facility, Medical Center—University of Freiburg, 79106 Freiburg, Germany
- PhD Program, Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany
| | - Jamal Alzubi
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
| | - Manuel Rhiel
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
| | - Kay O. Chmielewski
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
- PhD Program, Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany
| | - Laura Mosti
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
| | - Julia Rositzka
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
| | - Marcel Heugel
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
| | - Jan Lawrenz
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
| | - Valentina Pennucci
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
| | - Birgitta Gläser
- Institute of Human Genetics, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (B.G.); (J.F.)
| | - Judith Fischer
- Institute of Human Genetics, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (B.G.); (J.F.)
- Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
| | - Axel Schambach
- Institute for Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany; (A.S.); (T.M.)
- REBIRTH Center for Regenerative and Translational Medicine, Hannover Medical School, 30625 Hannover, Germany;
| | - Thomas Moritz
- Institute for Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany; (A.S.); (T.M.)
- REBIRTH Center for Regenerative and Translational Medicine, Hannover Medical School, 30625 Hannover, Germany;
| | - Nico Lachmann
- REBIRTH Center for Regenerative and Translational Medicine, Hannover Medical School, 30625 Hannover, Germany;
- Department of Pediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, 30625 Hannover, Germany
- Biomedical Research in Endstage and Obstructive Lung Disease, German Center for Lung Research, Hannover Medical School, 30625 Hannover, Germany
- Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, 30625 Hannover, Germany
- Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 30625 Hannover, Germany
| | - Tatjana I. Cornu
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
- Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
| | - Claudio Mussolino
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
- Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
| | - Richard Schäfer
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
- Freiburg iPS Core Facility, Medical Center—University of Freiburg, 79106 Freiburg, Germany
- Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
| | - Toni Cathomen
- Institute for Transfusion Medicine and Gene Therapy, Medical Center—University of Freiburg, 79106 Freiburg, Germany; (R.H.); (J.A.); (M.R.); (K.O.C.); (L.M.); (J.R.); (M.H.); (V.P.); (T.I.C.); (C.M.); (R.S.)
- Center for Chronic Immunodeficiency (CCI), Medical Center—University of Freiburg, 79106 Freiburg, Germany
- Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
| |
Collapse
|